NCT06878274View on ClinicalTrials.gov

Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

February 29, 2028

Study Completion Date

February 28, 2030

Conditions
Non Small Cell Lung CancerStage III Lung Cancer
Interventions
RADIATION

Post-operative radiotherapy

Mediastinal post-operative radiotherapy to a dose of 40 Gy in 15 fractions

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER